Showing results (301-310 of 8,075) with videos related to
Sort By:
Pageof 808
Clinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of therapies for rheumatoid arthritis: underestimation of the "side effects" or risks of RA leads to underestimation of the benefit/risk of therapiesT Pincus, A Kavanaugh, T SokkaClinical and Experimental Rheumatology|November 24, 2004
Quantitative documentation of benefit/risk of new therapies for rheumatoid arthritis: patient questionnaires as an optimal measure in standard careT Pincus, T Sokka, A KavanaughClinical and Experimental Rheumatology|November 24, 2004
Mandatory pharmacosurveillance--a Canadian model for access to therapy and researchS G Barr, L Martin, C Chung, et al.Clinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of leflunomide in rheumatoid arthritisJ M Kremer, G W CannonClinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of cyclosporine in rheumatoid arthritisE Gremese, G F FerraccioliClinical and Experimental Rheumatology|November 24, 2004
Switching between biological agentsR F van VollenhovenClinical and Experimental Rheumatology|November 24, 2004
Benefits and risks of biological agents: lymphomasR F van VollenhovenClinical and Experimental Rheumatology|March 26, 2005
Chondrocyte-mediated collagenolysis correlates with cartilage destruction grades in osteoarthritisY T Konttinen, J Ma, P Ruuttilal, et al.Clinical and Experimental Rheumatology|March 26, 2005
Hashimoto's thyroiditis is associated with peripheral lymphocyte activation in patients with systemic sclerosisB Farzati, G Mazziotti, G Cuomo, et al.Clinical and Experimental Rheumatology|March 26, 2005
Steroid-responsive inclusion body myositis associated with endometrial cancerD T Alexandrescu, N S Bhagwati, B Fomberstein, et al.Pageof 808